Jean Coutu Group (PJC) (A) (PJC.A.TO)

BUY
Could dribble down a bit because it has to accomplish its US acquisition. Very competent people.
TOP PICK
(Past top pick May 7/04. Down 5%.) Likes their home court advantage in the province of Québec. Also likes their acquisition of Eckerd drugs in the US. Well-financed.
WATCH
The recent acquisition of the Eckerd stores has put a lot of financial risk into this company. It could be a big win, but he will wait and watch.
TOP PICK
Has significant upside. Have a good understanding of their competitors in the US. Should be able to integrate the Eckard chain well.
STRONG BUY
Likes its potential. The fourth largest drug chain in North America. 90% of its earnings will be out of the US which is good. Eckard Drugs will be a big moneymaker for them. Have taken on a lot of debt.
TOP PICK
With its acquisition of the Eastern Seaboard stores of Eckerd drugs, it is the 4th largest drugstore chain in North America. US investors have not discovered it yet. Very good demographics. Excellent operators.
BUY
The purchase of Eckerd Drugs in the US, with their expertise in managing stores, could put some momentum behind their earnings.
BUY ON WEAKNESS
Have made acquisitions, but haven't financed them yet. Could do it by a debt issue or equity issue or by selling some of the Eckhard stores.
TOP PICK
Likes, good sector, likes take over
TOP PICK
Likes merger, good entry level.
TOP PICK
Underappreciated stock. Likes their purchase of Eckerd drugs. This doubles the number of stores in the US. A defensive growth company.
WATCH
Well-managed company. Acquisition of Eckerd Drugs could be more of a problem then their last acquisition. It could be a big success for them but it has to be turned around. Trying to do their homework on it before they buy.
TOP PICK
Is now going to be the 4th largest drugstore chain in North America after their acquisition of Eckerd's. Lots of growth opportunities. Excellent management and should be able to get some profit out of their new acquisition.
WAIT
At a valuation high. Acquisition of Eckerd's in the US is a concern. Wait to see how they execute on this.
BUY
Has a whole new growth potential with their purchase of Eckerd drugs in the US.
Showing 151 to 165 of 204 entries